Shandong Weigao Orthopaedic Device Co., Ltd (SHA: 688161)

Shandong Weigao Orthopaedic Device Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	1,283	1,282	2,057	2,152	1,822	1,573
Other Revenue	1.33	1.33	0.93	1.58	1.47	1.35
Revenue	1,284	1,284	2,058	2,154	1,824	1,574
Revenue Growth (YoY)	-19.44%	-37.63%	-4.44%	18.08%	15.87%	29.96%
Cost of Revenue	497.89	460.3	489.5	409.09	338.96	285.86
Gross Profit	786.41	823.24	1,568	1,744	1,485	1,288
Selling, General & Admin	547.85	621.81	786.46	827.36	710.75	689.29
Research & Development	134.71	130.2	117.66	121.23	82.46	74.09
Other Operating Expenses	8.02	14.21	28.89	31.26	40.25	26.16
Operating Expenses	686.82	760.93	948.03	983.99	837.56	797.15
Operating Income	99.59	62.31	620.45	760.46	647.25	491
Interest Expense	-0.86	-0.95	-0.61	-0.61	-	-
Interest & Investment Income	53.11	56.11	64.57	42.93	15.41	13.9
Currency Exchange Gain (Loss)	-1.24	-1.24	2.18	-0.51	-2.44	1.05
Other Non Operating Income (Expenses)	6.74	10.71	6.02	-6.28	-0.35	-0.24
EBT Excluding Unusual Items	157.33	126.94	692.6	795.99	659.88	505.7
Impairment of Goodwill	-0.17	-0.17	-	-	-	-
Gain (Loss) on Sale of Assets	-0.23	-0.02	0.23	-0.11	-0.45	0.03
Asset Writedown	26.86	-	-	-	-1.6	-0.01
Other Unusual Items	4.86	4.86	13.38	14.05	8.2	6.21
Pretax Income	188.75	131.62	706.21	809.93	666.03	511.93
Income Tax Expense	29.11	18.53	105.85	118.59	104.31	70.8
Earnings From Continuing Operations	159.64	113.09	600.36	691.33	561.72	441.14
Minority Interest in Earnings	-5.04	-0.78	0.35	-1.01	-3.32	0.53
Net Income	154.6	112.32	600.7	690.32	558.4	441.67
Net Income to Common	154.6	112.32	600.7	690.32	558.4	441.67
Net Income Growth	-35.09%	-81.30%	-12.98%	23.62%	26.43%	36.17%
Shares Outstanding (Basic)	406	401	400	379	358	332
Shares Outstanding (Diluted)	406	401	400	379	358	332
Shares Change (YoY)	2.82%	0.16%	5.58%	5.96%	7.79%	49.48%
EPS (Basic)	0.38	0.28	1.50	1.82	1.56	1.33
EPS (Diluted)	0.38	0.28	1.50	1.82	1.56	1.33
EPS Growth	-36.87%	-81.33%	-17.58%	16.67%	17.29%	-8.90%
Free Cash Flow	189.96	76.46	392.8	675.84	594.54	505.21
Free Cash Flow Per Share	0.47	0.19	0.98	1.78	1.66	1.52
Dividend Per Share	0.240	0.120	0.410	0.520	-	-
Dividend Growth	-41.35%	-70.61%	-21.15%	-	-	-
Gross Margin	61.23%	64.14%	76.21%	81.00%	81.41%	81.84%
Operating Margin	7.75%	4.85%	30.15%	35.31%	35.49%	31.19%
Profit Margin	12.04%	8.75%	29.19%	32.05%	30.62%	28.06%
Free Cash Flow Margin	14.79%	5.96%	19.09%	31.38%	32.60%	32.10%
EBITDA	155.55	118.68	677.35	811.94	688.9	526.78
EBITDA Margin	12.11%	9.25%	32.91%	37.70%	37.77%	33.47%
D&A For EBITDA	55.96	56.37	56.91	51.48	41.65	35.79
EBIT	99.59	62.31	620.45	760.46	647.25	491
EBIT Margin	7.75%	4.85%	30.15%	35.31%	35.49%	31.19%
Effective Tax Rate	15.42%	14.08%	14.99%	14.64%	15.66%	13.83%
Revenue as Reported	1,284	1,284	2,058	2,154	1,824	-

Source: S&P Capital IQ. Standard template. Financial Sources.